Meadows Benjamin purchased $10K of QTRX
Meadows Benjamin (Chief Commercial Officer) purchased 3,500 shares of Quanterix Corp (QTRX) at $2.77 on 2026-05-12.
Quanterix Corp
No enriched coverage for $QTRX in the last 7 days.
No SEC Form 4 filings for $QTRX in the last 30 days.
Meadows Benjamin (Chief Commercial Officer) purchased 3,500 shares of Quanterix Corp (QTRX) at $2.77 on 2026-05-12.
Quanterix Corp (QTRX) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. qtrx-20260609 Quanterix Corp false 0001503274 0001503274 2026-06-09 2026-06-09 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________________ FORM 8-K ______________________________________ CURRENT REPORT Pursuant to Section 13 or 1
Quanterix Corp. (QTRX) appointed Jason Faessler as CFO effective June 22, succeeding Vandana Sriram, who has served since August 2023 and will step down. Faessler joins from Bruker Corp., where he led global FP&A and Americas finance. Shares fell in premarket, down 3.09% to $3.0332 after a 5.15% decline Monday.
Recent QTRX coverage spans financial news, corporate actions and insider activity.
The Form 4 discloses an insider buy, but the disclosed size is modest and lacks new operational or financial catalysts.
Board/equity-plan outcomes can affect governance optics and future share issuance expectations, but this filing is not a fundamental operating update.
CFO succession is a governance/operational signal; near-term trading impact is likely sentiment-driven rather than fundamentals, unless investors view the transition as a risk.
The filing is a corporate/officer change with detailed compensation, which can modestly affect near-term sentiment but is not an earnings or guidance catalyst.
Insider buying/small disposition can reinforce confidence, but the main tradable driver is the immediate reaction to the filing plus guidance context.
alphai scores every news story that mentions QTRX with an AI model for sentiment and relevance, and aggregates insider trades from Quanterix Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
Meadows Benjamin (Chief Commercial Officer) purchased 3,500 shares of Quanterix Corp (QTRX) at $2.77 on 2026-05-12.
2 min readQuanterix Corp (QTRX) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. qtrx-20260609 Quanterix Corp false 0001503274 0001503274 2026-06-09 2026-06-09 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________________ FORM 8-K ______________________________________ CURRENT REPORT Pursuant to Section 13 or 1
2 min readQuanterix Corp. (QTRX) appointed Jason Faessler as CFO effective June 22, succeeding Vandana Sriram, who has served since August 2023 and will step down. Faessler joins from Bruker Corp., where he led global FP&A and Americas finance. Shares fell in premarket, down 3.09% to $3.0332 after a 5.15% decline Monday.
2 min readQuanterix Corp (QTRX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 exhibit101-qtrxx20260609.htm EX-10.1 Document Exhibit 10.1 Quanterix 900 Middlesex Turnpike | Building 1 Billerica, MA 01821 Jason Faessler Delivered via Email Re: Employment Agreement Dear Jason: Quanterix Corporation (the "Company") is pleased to offer you the full-ti
2 min readTurn Therapeutics (TTRX) rose over 20% after interim Phase 2 results for GX-03 in atopic dermatitis, with 92.6% achieving EASI-50 at 4 weeks. Conexeu (CNXU) gained ~19% on preclinical B.R.E.A.S.T. bioprinting progress. Rallybio (RLYB) jumped on plans to acquire Avenzo via a $215M investment. LIXTE (LIXT) surged on an AI energy pivot; Quanterix (QTRX) rose on insider SEC filing.
7 min readQuanterix CFO Vandana Sriram reported routine equity compensation activity involving Restricted Stock Units (RSUs). On May 15, 2026, RSUs converted into common stock in several tranches, and shares were disposed of to cover tax obligations. Following these transactions, the CFO directly held 28,897 shares of Quanterix common stock.
2 min readQuanterix Corp's Chief Technology Officer, Michael Francis Miller, received 1,558 shares of common stock on May 15, 2026, due to the vesting of restricted stock units. Concurrently, 467 shares were withheld at $2.75 per share to cover tax obligations. Following these transactions, Miller directly owns 32,694 common shares and 760 restricted stock units.
2 min readAMERIPRISE FINANCIAL INC has significantly reduced its stake in Quanterix Corp (QTRX) by 80.18%, selling 4,005,849 shares at $3.13 each. This move leaves the investment firm with 990,224 shares of Quanterix, representing 2.10% of its portfolio. The transaction reflects a strategic reallocation by AMERIPRISE FINANCIAL, possibly due to Quanterix's underperformance, as the stock has since declined by 8.15% and has a low GF Score of 67/100, indicating poor future performance and potential as a value trap despite being significantly undervalued.
2 min readAmeriprise Financial, Inc. has filed an Amendment No. 6 to a Schedule 13G/A, reporting shared voting and dispositive power over 990,224 shares of Quanterix Corp (QTRX) common stock, which represents 2.1% of the class. The filing clarifies that Ameriprise disclaims beneficial ownership of these shares and that the stake is considered a passive investment, unlikely to influence governance. This disclosure is a routine update on institutional holdings in Quanterix.
2 min readCanaccord Genuity has reiterated its 'Hold' rating on Quanterix, indicating a maintained stance on the company's stock. This suggests that the analyst firm views Quanterix as appropriately valued or sees no immediate catalysts for a significant price movement in either direction. Investors and market watchers should note that a "Hold" rating typically implies that analysts advise current shareholders to retain their positions rather than buying more or selling.
2 min read